Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre studyW Victoria Lai, Louisiane Lebas, Tristan A Barnes, et al.
JAMA Oncology|December 1, 2017
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET StudyEli L Diamond, Vivek Subbiah, A Craig Lockhart, et al.
Cancer Discovery|October 18, 2014
Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disordersDavid M Hyman, Eli L Diamond, Cecile Rose T Vibat, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2017
DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial CarcinomaMin Yuen Teo, Richard M Bambury, Emily C Zabor, et al.
The Oncologist|August 17, 2023
Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung CancerArielle Elkrief, Biagio Riccuiti, Joao V Alessi, et al.
JCO Precision Oncology|September 15, 2018
Clinicopathologic Features of Non-Small-Cell Lung Cancer Harboring anAnna F Farago, Martin S Taylor, Robert C Doebele, et al.
European Urology Focus|September 28, 2017
Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell CarcinomaJozefina Casuscelli, Maria F Becerra, Brandon J Manley, et al.
The Journal of Molecular Diagnostics : JMD|February 6, 2018
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular PathologyNeal I Lindeman, Philip T Cagle, Dara L Aisner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
The American Journal of Surgical Pathology|October 11, 2019
TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic CorrelationsSounak Gupta, Pedram Argani, Achim A Jungbluth, et al.
Pageof 20